Superbugs now resistant to key everyday antibiotics: ICMR

ICMR's annual report 2024 'Antimicrobial Resistance Research & Surveillance Network (AMRSN)', showed that routine drugs like fluoroquinolones, third-generation cephalosporins, carbapenems and piperacillin-tazobactam are rapidly losing effectiveness against bacteria most frequently seen in hospitals.